Organization & Developments: Maxion Therapeutics

Parents

*Antibody-like therapeutics to solve ion channel and GPCR-driven diseases.
*Combines mini-proteins found in venom and other sources called knottins into the antibody surface to create mixtures while creating the optimum drug-like properties of antibodies to treat diseases such as chronic pain, autoimmune disorders, and heart disease.
*Maxion Therapeutics is a biotechnology company developing antibody-based drugs for previously untreatable ion channel- and G protein-coupled receptor (GPCR)-driven diseases, including autoimmune conditions, chronic pain, and cardiovascular disease